| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $11,913,726 ) (Continued on the next page) |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 001 | 6 | NIH | 4/16/2024 | $493,946 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15GM129731 | Acquiring Nanoparticle Tracking Analysis System to Enhance Lab Productivity and Capability | 000 | 2 | NIH | 5/1/2024 | $98,046 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL139554 | Structural enzymology of protein C | 001 | 7 | NIH | 6/20/2024 | $43,185 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL139554 | Structural enzymology of protein C | 000 | 7 | NIH | 4/25/2024 | $485,833 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DE025141 | Developing new therapeutic strategies against head and neck cancer | 001 | 8 | NIH | 6/6/2024 | $38,457 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DE025141 | Developing new therapeutic strategies against head and neck cancer | 000 | 8 | NIH | 3/12/2024 | $432,620 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK095112 | Regulatory Role of Transferrin in Erythropoiesis and Iron Metabolism | 000 | 7 | NIH | 6/13/2024 | $679,795 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K22CA279495 | Elucidating Mechanisms of CAR ML NK cell biology to treat cancer and infection | 000 | 1 | NIH | 1/23/2024 | $186,030 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21HL173848 | Introducing NanoProTEN, a novel approach for anticoagulation in patients with prothrombotic autoantibodies | 000 | 1 | NIH | 3/29/2024 | $227,250 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG083451 | An investigation of the response of preclinical mouse models of dementia to adropin therapy | 000 | 1 | NIH | 4/12/2024 | $416,625 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM154323 | Mechanism of homologous recombination driven by the intrinsically disordered domain of tumor suppressor PALB2 | 000 | 1 | NIH | 4/26/2024 | $303,000 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG087308 | Methods for treating aging-related cognitive decline and reducing risk of AD/ADRD by enhancing the endogenous expression of adropin | 000 | 1 | NIH | 4/12/2024 | $416,625 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK132162 | Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH | 001 | 2 | NIH | 5/15/2024 | $35,432 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK132162 | Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH | 000 | 2 | NIH | 12/8/2023 | $531,461 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23AR079035 | Neighborhood Barriers and Facilitators to Walking, the Epidemiology of Knee Osteoarthritis and Developing Effective Exercise Prescriptions | 000 | 3 | NIH | 1/25/2024 | $157,393 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21CA277436 | GPR160 antibody development for cancer treatment | 000 | 2 | NIH | 6/25/2024 | $168,212 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15DC021563 | Speech Localization and Enhancement for Next-Generation Hearing Devices | 000 | 1 | NIH | 1/31/2024 | $451,688 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM152125 | Methods and technologies for chemical synthesis of glycans | 000 | 1 | NIH | 1/26/2024 | $439,023 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM145783 | Structural dynamics of sphingosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer | 000 | 1 | NIH | 6/6/2024 | $65,243 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM149320 | Coordination of DNA Metabolism by Replication Protein A | 002 | 2 | NIH | 6/21/2024 | $54,661 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM149320 | Coordination of DNA Metabolism by Replication Protein A | 001 | 2 | NIH | 5/24/2024 | $199,984 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM149320 | Coordination of DNA Metabolism by Replication Protein A | 000 | 2 | NIH | 4/3/2024 | $491,951 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R03AI178368 | Transcriptomic Quantitation of Hepatitis B Virus Surface Antigen from Integration | 000 | 2 | NIH | 3/18/2024 | $75,750 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AR081270 | Development of Injectable Super-Lubricious Microgels for Sustained Release of Platelet-Rich Plasma to Treat Post-Traumatic Osteoarthritis | 001 | 2 | NIH | 6/11/2024 | $40,152 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AR081270 | Development of Injectable Super-Lubricious Microgels for Sustained Release of Platelet-Rich Plasma to Treat Post-Traumatic Osteoarthritis | 000 | 2 | NIH | 3/28/2024 | $516,254 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01ES034383 | Halolipid-Neutrophil Extracellular Trap Axis in Halogen Lung Injury | 000 | 3 | NIH | 7/12/2024 | $450,008 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA261979 | Fingolimod and Ozanimod for the treatment and prevention of chemobrain | 000 | 3 | NIH | 7/9/2024 | $458,752 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM143179 | Mechanism and Regulation of eIF6 in Translation | 001 | 3 | NIH | 7/23/2024 | $31,815 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM143179 | Mechanism and Regulation of eIF6 in Translation | 000 | 3 | NIH | 4/9/2024 | $286,335 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL160553 | Clinically Meaningful PTSD Improvement: Reducing Risk for Adverse Outcomes in Comorbid Cardiometabolic Disease | 000 | 3 | NIH | 7/1/2024 | $404,899 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R37CA265877 | Novel molecular mechanism for extracellular release of proteins implicated in metastatic cancer | 000 | 3 | NIH | 7/5/2024 | $394,314 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23DA053433 | A Preconception Health Intervention to Reduce Substance Exposed Pregnancies among Incarcerated Women | 000 | 3 | NIH | 2/16/2024 | $177,480 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DC019566 | Pharmacological Approaches for Transepithelial Delivery of Therapeutics to the Vocal Folds | 000 | 3 | NIH | 3/26/2024 | $602,131 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI168543 | Th9 cells and protective TB immunity | 001 | 3 | NIH | 5/24/2024 | $66,759 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI168543 | Th9 cells and protective TB immunity | 000 | 3 | NIH | 2/27/2024 | $600,835 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | D1930852 | Nursing Workforce Diversity | 00 | 8 | HRSA | 6/10/2024 | $541,277 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK122401 | SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION | 000 | 5 | NIH | 5/9/2024 | $327,240 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL150146 | Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome | 001 | 5 | NIH | 6/13/2024 | $31,092 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL150146 | Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome | 000 | 5 | NIH | 1/10/2024 | $349,774 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 003 | 5 | NIH | 7/23/2024 | $511,779 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 002 | 5 | NIH | 6/11/2024 | $57,080 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 001 | 5 | NIH | 12/6/2023 | $0 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 001 | 5 | NIH | 12/6/2023 | $0 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 000 | 5 | NIH | 11/15/2023 | $256,617 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 000 | 5 | NIH | 11/15/2023 | $363,714 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | T7635369 | Maternal and Child Health Public Health Training Program | 00 | 5 | HRSA | 4/15/2024 | $348,143 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG089957 | Age, sex, hormonal status, and anti-inflammatory therapy for atherosclerosis | 000 | 1 | NIH | 7/18/2024 | $416,625 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK134531 | The Role of Inflammation in Regulating Gastric Metaplasia | 001 | 2 | NIH | 5/10/2024 | $33,397 |
| 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK134531 | The Role of Inflammation in Regulating Gastric Metaplasia | 000 | 2 | NIH | 12/13/2023 | $500,965 |
|